Genelux | Investor Presentation Deck | 37 slides · page 15 of 37
The slide uses a bar chart to compare efficacy metrics (RECIST1.1, CA-125, PFS-6-month) across various clinical studies, with Genelux's VIRO-15 trial highlighted.
Pitch deck · key_takeaways · summarize · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 disclaimer 1/1 list 1/1 table 1/1 title 2/2
Components 6
bar-grouped disclaimer bullet data action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1